PETER SEONGWOO HWANG,YOUNG-CHOON MOON,NEIL G. ALMSTEAD
申请号：
PT07838770
公开号：
PT2076501E
申请日:
2007.09.24
申请国别(地区):
PT
年份:
2016
代理人:
摘要：
The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay.
